NOVO NORDISK A S

NOVO NORDISK A S (ticker: NVO) is an NYSE-listed pharmaceutical preparations company. DredgeCap's structured extraction of NVO's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

NVO Risk Flags

Consolidated view of every risk_flag row NVOhas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

Category	Severity	Source	Excerpt	EDGAR
Auditor Change	low	20-F · Jan 31, 2024	PCAOB-tagged auditor in 20-F filed 2024-01-31 (accession 0001628280-24-002635) was 'Deloitte Statsautoriseret Revisionspartnerselskab' (PCAOB Firm ID: 1294). Prior 20-F filed 2023-02-01 (accession 0001628280-23-001868) was 'PricewaterhouseC…	view ↗

Related on NVO

Auditor & opinion →

Source for auditor_change + going-concern flags.

Share-count dilution →

Source for dilution + convertible-debt flags.

Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.